Adenotonsillectomy outcomes in obstructive sleep apnea (OSA) treatment among children with Prader-Willi syndrome (PWS) remain unclear. This study aimed to elucidate the effectiveness of adenotonsillectomy in OSA treatment among children with PWS.
Data Source
PubMed, MEDLINE, Embase, and Cochrane Review up to February 2019.
Review Methods
The registry number of the protocol published on PROSPERO was CRD42015027053. Two authors independently searched the relevant database. Polysomnography outcomes in these children were examined, including net postoperative changes in the apnea-hypopnea index (AHI), net postoperative changes in the minimum and mean oxygen saturation, the overall success rate for a postoperative AHI <1, and the overall success rate for a postoperative AHI <5.
Results
Six studies with 41 patients were analyzed (mean age, 5.0 years; 55% boys; mean sample size, 6.8 patients). All children had PWS and received adenotonsillectomy for the treatment of OSA. The AHI was 13.1 events per hour (95% CI, 11.0-15.1) before surgery and 4.6 events per hour (95% CI, 4.1-5.1) after surgery. The mean change in the AHI was a significant reduction of 8.0 events per hour (95% CI, −10.8 to −5.1). The overall success rate was 21% (95% CI, 11%-38%) for a postoperative AHI <1 and 71% (95% CI, 54%-83%) for a postoperative AHI <5. Some patients developed velopharyngeal insufficiency postoperatively.
Conclusion
Adenotonsillectomy was associated with OSA improvement among children with PWS. However, residual OSA was frequently observed postoperatively in these patients.
PraderALabhartAWilliH. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustandim Neugeborenenalter. Schweiz Med Wochenschr. 1956;86:1260-1261.
2.
NichollsRDKnollJHButlerMGKaramSLalandeM. Genetic imprinting suggested by maternal heterodisomy in nondeletion Prader-Willi syndrome. Nature. 1989;342:281-285.
WhittingtonJEHollandAJWebbTButlerJClarkeDBoerH. Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region. J Med Genet. 2001;38:792-798.
5.
BurdLVeselyBMartsolfJKerbeshianJ. Prevalence study of Prader-Willi syndrome in North Dakota. Am J Med Genet. 1990;37:97-99.
6.
HolmVACassidySBButlerMG, et al. Prader-Willi syndrome: consensus diagnostic criteria. Pediatrics. 1993;91:398-402.
7.
AnguloMAButlerMGCatalettoME. Prader-Willi syndrome: a review of clinical, genetic, and endocrine findings. J Endocrinol Invest. 2015;38:1249-1263.
8.
GoldstoneAPHollandAJHauffaBPHokken-KoelegaACTauberM; speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008;93:4183-4197.
9.
DealCLTonyMHöybyeCAllenDBTauberMChristiansenJS; 2011 Growth Hormone in Prader-Willi Syndrome Clinical Care Guidelines Workshop Participants. Growth Hormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013;98:E1072-E1087.
10.
CamffermanDMcEvoyRDO’DonoghueFLushingtonK. Prader Willi syndrome and excessive daytime sleepiness. Sleep Med Rev. 2008;12:65-75.
11.
NixonGMBrouilletteRT. Sleep and breathing in Prader-Willi syndrome. Pediatr Pulmonol. 2002;34:209-217.
12.
MillerJWagnerM. Prader-Willi syndrome and sleep-disordered breathing. Pediatr Ann. 2013;42:200-204.
13.
O’DonoghueFJCamffermanDKennedyJD, et al. Sleep-disordered breathing in Prader-Willi syndrome and its association with neurobehavioral abnormalities. J Pediatr. 2005;147:823-829.
14.
FestenDAde WeerdAWvan den BosscheRAJoostenKHoeveHHokken-KoelegaAC. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab. 2006;91:4911-4915.
15.
LinHYLinSPLinCC, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol. 2007;42:881-887.
16.
WilliamsKScheimannASuttonVHayslettEGlazeDG. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. J Clin Sleep Med. 2008;4:111-118.
17.
BruniOVerrilloENovelliLFerriR. Prader-Willi syndrome: sorting out the relationships between obesity, hypersomnia, and sleep apnea. Curr Opin Pulm Med. 2010;16:568-573.
18.
VandeleurMDaveyMJNixonGM. Are sleep studies helpful in children with Prader-Willi syndrome prior to commencement of growth hormone therapy?J Paediatr Child Health. 2013;49:238-241.
19.
Al-SalehSAl-NaimiAHamiltonJZweerinkAIaboniANarangI. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi Syndrome during 2 years of growth hormone therapy. J Pediatr. 2013;162:263-268.
20.
CohenMHamiltonJNarangI. Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi Syndrome. PLoS One. 2014;9(6):e101012.
21.
PavoneMCaldarelliVKhiraniS, et al. Sleep disordered breathing in patients with Prader-Willi syndrome: a multicenter study. Pediatr Pulmonol. 2015;50:1354-1359.
22.
KhayatANarangIBin-HasanSAminRAl-SalehS. Longitudinal evaluation of sleep disordered breathing in infants with Prader-Willi syndrome. Arch Dis Child. 2017;102:634-638.
23.
CanoraAFranzeseAMozzilloEFattorussoVBocchinoMSanduzziA. Severe obstructive sleep disorders in Prader-Willi syndrome patients in southern Italy. Eur J Pediatr. 2018;177:1367-1370.
24.
LumengJCChervinRD. Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008;5:242-252.
25.
SedkyKBennettDSPumariegaA. Prader Willi syndrome and obstructive sleep apnea: co-occurrence in the pediatric population. J Clin Sleep Med. 2014;10:403-409.
26.
CapdevilaOSKheirandish-GozalLDayyatEGozalD. Pediatric obstructive sleep apnea: complications, management, and long-term outcomes. Proc Am Thorac Soc. 2008;5:274-282.
27.
KangKTChiuSNWengWCLeePLHsuWC. Analysis of 24-hour ambulatory blood pressure monitoring in children with obstructive sleep apnea: a hospital-based study. Medicine. 2015;94:e1568.
28.
KangKTChiuSNWengWCLeePLHsuWC. Comparisons of office and 24-hour ambulatory blood pressure monitoring in children with obstructive sleep apnea. J Pediatr. 2017;182:177-183.
29.
KangKTChouCHWengWCLeePLHsuWC. Associations between adenotonsillar hypertrophy, age, and obesity in children with obstructive sleep apnea. PLoS One. 2013;8(10):e78666.
30.
LeeCHHsuWCChangWHLinMTKangKT. Polysomnographic findings after adenotonsillectomy for obstructive sleep apnea in obese and non-obese children: a systematic review and meta-analysis. Clin Otolaryngol. 2016;41:498-510.
31.
LeeCFHsuWCLeeCHLinMTKangKT. Treatment outcomes of supraglottoplasty for pediatric obstructive sleep apnea: a meta-analysis. Int J Pediatr Otorhinolaryngol. 2016;87:18-27.
32.
KangKTKoltaiPJLeeCHLinMTHsuWC. Lingual tonsillectomy for treatment of pediatric obstructive sleep apnea: a meta-analysis. JAMA Otolaryngol Head Neck Surg. 2017;143:561-568.
33.
MarcusCLMooreRHRosenCL, et al. A randomized trial of adenotonsillectomy for childhood sleep apnea. N Engl J Med. 2013;368:2366-2376.
34.
HsuWCKangKTWengWCLeePL. Impacts of body weight after surgery for obstructive sleep apnea in children. Int J Obes. 2013;37:527-531.
35.
FarhoodZIsleyJWOngAA, et al. Adenotonsillectomy outcomes in patients with Down syndrome and obstructive sleep apnea. Laryngoscope. 2017;127:1465-1470.
36.
NationJBriggerM. The efficacy of adenotonsillectomy for obstructive sleep apnea in children with Down syndrome: a systematic review. Otolaryngol Head Neck Surg. 2017;157:401-408.
MoherDLiberatiATetzlaffJAltmanDG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006-1012.
39.
KangKTChangISTsengCC, et al. Impacts of disease severity on postoperative complications in children with sleep-disordered breathing. Laryngoscope. 2017;127:2646-2652.
40.
ChangISKangKTTsengCC, et al. Revisits after adenotonsillectomy in children with sleep-disordered breathing: a retrospective single-institution study. Clin Otolaryngol. 2018;43:39-46.
HigginsJPThompsonSGDeeksJJAltmanDG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
43.
PavoneMPagliettiMGPetroneACrinòADe VincentiisGCCutreraR. Adenotonsillectomy for obstructive sleep apnea in children with Prader-Willi syndrome. Pediatr Pulmonol. 2006;41:74-79.
44.
TannaNChoiSS. Efficacy and safety of adenotonsillectomy for pediatric obstructive sleep apnea in Prader-Willi syndrome. Ann Otol Rhinol Laryngol. 2009;118:267-269.
45.
DeMarcantonioMADarrowDHGyuricskoEDerkayCS. Obstructive sleep disorders in Prader-Willi syndrome: the role of surgery and growth hormone. Int J Pediatr Otorhinolaryngol. 2010;74:1270-1272.
46.
MeyerSLSplaingardMRepaskeDRZipfWAtkinsJJatanaK. Outcomes of adenotonsillectomy in patients with Prader-Willi syndrome. Arch Otolaryngol Head Neck Surg. 2012;138:1047-1051.
47.
CrockettDJAhmedSRSowderDRWoottenCTChinnaduraiSGoudySL. Velopharyngeal dysfunction in children with Prader-Willi syndrome after adenotonsillectomy. Int J Pediatr Otorhinolaryngol. 2014;78:1731-1734.
48.
GiordanoLTomaSPalontaF, et al. Obstructive sleep apnea in Prader-Willi syndrome: risks and advantages of adenotonsillectomy. Pediatr Med Chir. 2015;37:pmc.2015.107.
49.
PadiaRMuntzHPfefferKMeierJ. Effectiveness of adenotonsillectomy and risk of velopharyngeal insufficiency in children with Prader-Willi syndrome. Ann Otol Rhinol Laryngol. 2017;126:733-738.
50.
De Luca CantoGPachêco-PereiraCAydinozS, et al. Adenotonsillectomy complications: a meta-analysis. Pediatrics. 2015;136:702-718.
51.
KangKTLeePLWengWCHsuWC. Body weight status and obstructive sleep apnea in children. Int J Obes. 2012;36:920-924.
52.
TanHLUrquhartDS. Respiratory complications in children with Prader Willi Syndrome. Paediatr Respir Rev. 2017;22:52-59.
53.
KhamiMTanSGlicksmanJTHuseinM. Incidence and risk factors of velopharyngeal insufficiency postadenotonsillectomy. Otolaryngol Head Neck Surg. 2015;153:1051-1055.
54.
MillerJSilversteinJShusterJDriscollDJWagnerM. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J Clin Endocrinol Metab. 2006;91(2):413-417.
55.
Al-SalehSAl-NaimiAHamiltonJZweerinkAIaboniANarangI. Longitudinal evaluation of sleep-disordered breathing in children with Prader-Willi syndrome during 2 years of growth hormone therapy. J Pediatr. 2013;162:263-268.
56.
KangKTWengWCLeeCH, et al. Detection of pediatric obstructive sleep apnea syndrome: history or anatomical findings?Sleep Med. 2015;16:617-624.
57.
KangKTWengWCLeeCHHsiaoTYLeePLHsuWC. Clinical risk assessment model for pediatric obstructive sleep apnea. Laryngoscope. 2016;126:2403-2409.
58.
KangKTWengWCYehTHLeePLHsuWC. Validation of the Chinese version OSA-18 quality of life questionnaire in Taiwanese children with obstructive sleep apnea. J Formos Med Assoc. 2014;113:454-462.
59.
KangKTWengWCLeeCHLeePLHsuWC. Discrepancy between objective and subjective outcomes after adenotonsillectomy in children with obstructive sleep apnea syndrome. Otolaryngol Head Neck Surg. 2014;151:150-158.
60.
LeeCHKangKTWengWCLeePLHsuWC. Quality of life after adenotonsillectomy for children with sleep-disordered breathing: a linear mixed model analysis. Int J Pediatr Otorhinolaryngol. 2014;78:1374-1380.
61.
LeeCHKangKTWengWCLeePLHsuWC. Quality of life after adenotonsillectomy in children with obstructive sleep apnea: short-term and long-term results. Int J Pediatr Otorhinolaryngol. 2015;79:210-215.
62.
WongCPNgDKMaTMChauCChowPYKwokKL. Improvement in quality of life after adenotonsillectomy in a child with Prader Willi syndrome. Sleep Breath. 2010;14:167-170.
63.
KuoYLKangKTChiuSNWengWCLeePLHsuWC. Blood pressure after surgery among obese and non-obese children with obstructive sleep apnea. Otolaryngol Head Neck Surg. 2015;152:931-940.
64.
LeeCHKangKTChiuSN, et al. Association of adenotonsillectomy with blood pressure among hypertensive and nonhypertensive children with obstructive sleep apnea. JAMA Otolaryngol Head Neck Surg. 2018;144:300-307.
65.
HsuWCKangKTChiuSNWengWCLeePLLinCY. 24-hour ambulatory blood pressure after adenotonsillectomy in childhood sleep apnea: a prospective 3-month follow-up study. J Pediatr. 2018;199:112-117.
66.
KangKTChiuSNLinCYWengWCLeePLHsuWC. Effect of adenotonsillectomy on 24-hour ambulatory blood pressure in children with obstructive sleep apnea: prospective six-month follow-up study. Otolaryngol Head Neck Surg. 2019;160:911-921.
67.
BergeronMDugginsALCohenAP, et al. A shared decision-making tool for obstructive sleep apnea without tonsillar hypertrophy: a randomized controlled trial. Laryngoscope. 2018;128:1007-1015.
68.
BergeronMDugginsAChiniBIshmanSL. Clinical outcomes after shared decision-making tools with families of children with obstructive sleep apnea without tonsillar hypertrophy [published online January7, 2019]. Laryngoscope. doi:10.1002/lary.27653
69.
TangAGroplerMDugginsAL, et al. Gaps in evidence: management of pediatric obstructive sleep apnea without tonsillar hypertrophy. Laryngoscope. 2016;126:758-762.
70.
LeeCFLeeCHHsuehWYLinMTKangKT. Prevalence of obstructive sleep apnea in children with Down syndrome: a meta-analysis. J Clin Sleep Med. 2018;14:867-875.
71.
LanMCHsuYBLanMY, et al. Drug-induced sleep endoscopy in children with Prader-Willi syndrome. Sleep Breath. 2016;20:1029-1034.
72.
HuangYSGuilleminaultCLeeLALinCHHwangFM. Treatment outcomes of adenotonsillectomy for children with obstructive sleep apnea: a prospective longitudinal study. Sleep. 2014;37:71-76.
73.
ChanKCAuCTHuiLLNgSKWingYKLiAM. How obstructive sleep apnea evolves from childhood to young adulthood—natural history from a 10-year follow-up study. Chest. 2019;156:120-130.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
